SYN-1140-M001
SYN-1140-M005
SYN-1140-M010
SYN-1140-M050
102992-312EA
119.08
USD
InStock
102992-312
102992-314
102992-316
102992-318
Neratinib ≥95%
Neratinib
Neratinib (HKI-272) is an orally available, irreversible tyrosine kinase inhibitor with IC(50) values of 59nM and 92nM for HER2 and EGFR, respectively. It is in development for the treatment of early- and late-stage HER2-positive breast cancer.